As stakeholder engagement has become increasingly science-based and evidence-driven, generating actionable evidence, including RWE and HEOR data, in a timely manner has become more important than ever. Further, the ability to anticipate, shape and optimize product development has become one of the most critical success factors for realizing an innovation’s full promise.
Through illustrative case studies and expert panel discussion, this webinar uncovers how integrated evidence generation planning – beginning early in the product development lifecycle – can optimize an asset’s value story, and lead to greater clinical and commercial success and improved patient outcomes.
